Elevated Fasting Total Plasma Homocysteine Levels and Cardiovascular Disease Outcomes in Maintenance Dialysis Patients: A Prospective Study
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
There is an excess prevalence of hyperhomocysteinemia in dialysis-dependent end-stage renal disease (ESRD) patients. Cross-sectional studies of the relationship between elevated total homocysteine (tHcy) levels and prevalent cardiovascular disease (CVD) in this patient population suffer from severe methodologic limitations. No prospective investigations examining the association between tHcy levels and the subsequent development of arteriosclerotic CVD outcomes among maintenance dialysis patients have been reported. To assess whether elevated plasma tHcy is an independent risk factor for incident CVD in dialysis-dependent ESRD patients, we studied 73 maintenance peritoneal dialysis or hemodialysis patients who received a baseline examination between March and December 1994, with follow-up through April 1, 1996. We determined the incidence of nonfatal and fatal CVD events, which included all validated coronary heart disease, cerebrovascular disease, and abdominal aortic/lower-extremity arterial disease outcomes. After a median follow-up of 17.0 months, 16 individuals experienced at least one arteriosclerotic CVD event. Cox proportional-hazards regression analyses, unadjusted and individually adjusted for creatinine, albumin, and total cholesterol levels, total/HDL cholesterol ratio, dialysis adequacy/residual renal function, baseline CVD, and the established CVD risk factors (ie, age, sex, smoking, hypertension, diabetes/glucose intolerance, and dyslipidemia) revealed that tHcy levels in the upper quartile (≥27.0 μmol/L) versus the lower three quartiles (<27.0 μmol/L) were associated with relative risk estimates (hazards ratios, with 95% confidence intervals for the occurrence of (pooled) nonfatal and fatal CVD ranging from 3.0 to 4.4; 95% confidence intervals (1.1-8.1) to (1.6-12.2). We conclude that the markedly elevated fasting tHcy levels found in dialysis-dependent ESRD patients may contribute independently to their excess incidence of fatal and nonfatal CVD outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cox, D. R., & Oakes, D. (2018) · Chapman & Hall/CRC eBooks · doi:10.1201/9781315137438 · Cited by 6,234
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,584
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972
Self-citationVascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.
Ks, M. (1969) · PubMed Central · Cited by 1,803
A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
Stampfer, M. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490070059042 · Cited by 1,709
Owen, W. F., Lew, N. L., Liu, Y., Lowrie, E. G., & Lazarus, J. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291404 · Cited by 1,404
(1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v72198 · Cited by 1,109
Cardiovascular disease after renal transplantation.
Kasiske, B. L., Guijarro, C., Massy, Z. A., Wiederkehr, M. R., & Ma, J. Z. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v71158 · Cited by 669
Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions
McNamara, J. R., & Schaefer, E. J. (1987) · Clinica Chimica Acta · doi:10.1016/0009-8981(87)90188-4 · Cited by 521
Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease
Foley, R. N., Parfrey, P. S., Harnett, J. D., Kent, G. M., Murray, D. C., & Barre, P. E. (1996) · Kidney International · doi:10.1038/ki.1996.194 · Cited by 492
Coronary risk prediction in adults (The Framingham Heart Study)
Wilson, P. W. F., Castelli, W. P., & Kannel, W. B. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90165-2 · Cited by 381
Robinson, K., Gupta, A., Dennis, V., Arheart, K., Chaudhary, D., Green, R., Vigo, P., Mayer, E. L., Selhub, J., Kutner, M., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2743 · Cited by 334
Self-citationLipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients.
Cressman, M. D., Heyka, R. J., Paganini, E. P., O'Neil, J., Skibinski, C. I., & Hoff, H. F. (1992) · Circulation · doi:10.1161/01.cir.86.2.475 · Cited by 281
Cardiovascular Risk Factors in Chronic Renal Failure and Hemodialysis Populations
Ma, K. W., Greene, E. L., & Raij, L. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80827-4 · Cited by 269
BRATTSTRÖM, L., LINDGREN, A., ISRAELSSON, B., MALINOW, M. R., NORRVING, B., UPSON, B., & HAMFELT, A. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01829.x · Cited by 257
Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure
Guttormsen, A. B., Ueland, P. M., Svarstad, E., & Refsum, H. (1997) · Kidney International · doi:10.1038/ki.1997.359 · Cited by 247
High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients
Bostom, A. G., Shemin, D., Lapane, K. L., Hume, A. L., Yoburn, D., Nadeau, M. R., Bendich, A., Selhub, J., & Rosenberg, I. H. (1996) · Kidney International · doi:10.1038/ki.1996.19 · Cited by 240
Self-citationNet uptake of plasma homocysteine by the rat kidney in vivo
Bostom, A., Brosnan, J. T., Hall, B., Nadeau, M. R., & Selhub, J. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05522-x · Cited by 212
Self-citationHyperhomocysteinemia and the risk for vascular disease in hemodialysis patients.
Bachmann, J., Tepel, M., Raidt, H., Riezler, R., Graefe, U., Langer, K., & Zidek, W. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v61121 · Cited by 172
Bostom, A. G., Shemin, D., Lapane, K. L., Miller, J. W., Sutherland, P., Nadeau, M., Seyoum, E., Hartman, W., Prior, R., Wilson, P. W. F., et al. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05470-4 · Cited by 171
Self-citationRelationship of coronary risk factors to hemodialysis-associated ischemic heart disease
Rostand, S. G., Kirk, K. A., & Rutsky, E. A. (1982) · Kidney International · doi:10.1038/ki.1982.170 · Cited by 153
Bostom, A. G., Shemin, D. G., Lapane, K. L., Nadeau, M., Sutherland, P. A., Chan, J. A.-W., Rozen, R. R., Yoburn, D. C., Jacques, P. F., Selhub, J., et al. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05809-1 · Cited by 121
Self-citationBostom, A. G., Shemin, D. G., Lapane, K. L., Sutherland, P. A., Nadeau, M., Wilson, P. W. F., Yoburn, D. C., Bausserman, L., Tofler, G. H., Jacques, P. F., et al. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05865-0 · Cited by 118
Self-citationBostom, A. G., Shemin, D. G., Yoburn, D. C., et al. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05705-6 · Cited by 52
Self-citation
Cited by
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768
Homocysteine and Cardiovascular Disease
Refsum, H., Ueland, P. M., Nygård, O., & Vollset, S. E. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.31 · Cited by 2,180
Plasma Homocysteine as a Risk Factor for Vascular Disease: The European Concerted Action Project
Graham, I. M. (1997) · JAMA · doi:10.1001/jama.1997.03540460039030 · Cited by 1,738
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
(2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.01.019 · Cited by 1,427
Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients
Kalantar-Zadeh, K., Block, G., Humphreys, M. H., & Kopple, J. D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00803.x · Cited by 1,247
Metadata
- Authors
- Bostom, A. G., Shemin, D., Verhoef, P., Nadeau, M. R., Jacques, P. F., Selhub, J., Dworkin, L., & Rosenberg, I. H.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1997-11
- Volume
- 17
- Issue
- 11
- Pages
- 2554-2558
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W1988068836
- Cited by
- 294
- References
- 24
- FWCI
- 13.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.